Monjuvi Interactions
There are 319 drugs known to interact with Monjuvi (tafasitamab), along with 2 disease interactions. Of the total drug interactions, 51 are major, and 268 are moderate.
- View all 319 medications that may interact with Monjuvi
- View Monjuvi disease interactions (2)
Most frequently checked interactions
View interaction reports for Monjuvi (tafasitamab) and the medicines listed below.
- acetaminophen
- acetaminophen / hydrocodone
- acetaminophen / propoxyphene
- acyclovir
- acyclovir topical
- amoxicillin / clavulanate
- atorvastatin
- baclofen
- carvedilol
- ciprofloxacin
- clobetasol topical
- Crestor (rosuvastatin)
- cyclobenzaprine
- diclofenac
- doxycycline
- Eliquis (apixaban)
- gabapentin
- losartan
- magnesium gluconate
- melatonin
- metoprolol
- Metoprolol Tartrate (metoprolol)
- montelukast
- Protonix (pantoprazole)
- Revlimid (lenalidomide)
- Synthroid (levothyroxine)
- valacyclovir
- Valtrex (valacyclovir)
- Vitamin D3 (cholecalciferol)
- Xanax (alprazolam)
Monjuvi disease interactions
There are 2 disease interactions with Monjuvi (tafasitamab) which include:
Report options
More about Monjuvi (tafasitamab)
- Monjuvi consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: CD19 monoclonal antibodies
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Rituxan
Rituxan infusion is used to treat certain leukemias and lymphomas and some non-cancer conditions ...
Truxima
Truxima is used to treat non-Hodgkin's lymphoma, chronic lymphocytic leukemia, rheumatoid ...
Breyanzi
Breyanzi is a CAR T cell therapy for large B-cell lymphoma, CLL/SLL, follicular lymphoma, mantle ...
Kymriah
Kymriah is used to treat acute lymphoblastic leukemia (ALL) that is relapsing or refractory in ...
Polivy
Polivy (polatuzumab vedotin-piiq) is a targeted treatment that may be used to treat diffuse large ...
Yescarta
Yescarta is used to treat large B-cell lymphoma and follicular lymphoma, two types of non-Hodgkin ...
Xpovio
Xpovio is used to treat multiple myeloma (MM) or relapsed/refractory diffuse large B-cell lymphoma ...
Zynlonta
Zynlonta (loncastuximab tesirine) is used to treat relapsed or refractory diffuse large B-cell ...
Columvi
Columvi is used to treat certain types of diffuse large B-cell lymphoma (DLBCL) or large B-cell ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
